Filing Flows › Ocugen (OCGN) › Recalls, complaints & regulation
Ocugen (OCGN): clinical trials
Ocugen (OCGN) beyond its filings: 6 active clinical trials.
Ocugen's latest quarter
Ocugen, Q3 2026: revenue $2.0M (+11% year over year), operating margin -909.9%, net loss $3.6M, operating cash flow −$15.7M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Ocugen have?
6 active studies on ClinicalTrials.gov, 3 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.